Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 3 de 3
Filtrar
Mais filtros








Base de dados
Intervalo de ano de publicação
1.
Afr J Paediatr Surg ; 12(1): 71-3, 2015.
Artigo em Inglês | MEDLINE | ID: mdl-25659555

RESUMO

Massive purulent andacute pericarditis in children is a life-threatening disease associated with high mortality. It has been described tocomplicate usuallya bronchopulmonary infectionbut is currently uncommon in the era of antibiotics. Acute and massive purulent pericarditis has been rarely reported in children in association with human immunodeficiency virus (HIV) infection. This is a case of a10-year-old boy who presented with signs of sepsis and cardiac tamponade due to a massive staphylococcal purulent pericarditis complicating an unknown HIV infection.The child underwent pericardiectomy, intensive treatment, and survived this life-threatening disease.


Assuntos
Infecções por HIV/complicações , HIV , Abscesso Hepático/diagnóstico , Pericardiocentese/métodos , Pericardite/complicações , Infecções Estafilocócicas/complicações , Staphylococcus aureus/isolamento & purificação , Doença Aguda , Antibacterianos/uso terapêutico , Criança , Diagnóstico Diferencial , Infecções por HIV/diagnóstico , Humanos , Masculino , Pericardite/microbiologia , Pericardite/terapia , Infecções Estafilocócicas/diagnóstico , Infecções Estafilocócicas/cirurgia , Supuração , Tomografia Computadorizada por Raios X
3.
Zentralbl Gynakol ; 128(2): 82-6, 2006 Apr.
Artigo em Inglês | MEDLINE | ID: mdl-16673250

RESUMO

OBJECTIVE: The aim of this study was to assess the effectiveness of nevirapine (NVP) in the prevention of mother-to-child transmission (MTVT) of HIV-1 in children in the Yaounde University Teaching Hospital, Cameroon. METHODS: This was a prospective and descriptive hospital-based study in which pre-counselled HIV-infected pregnant women who gave their consent were included. At the onset of labour a single dose of 200 mg oral NVP was administered to each woman. Their newborns were also given 2 mg/kg of oral NVP syrup within 72 hours of their birth. These NVP-treated babies were assessed at 6 weeks, 6 months and between 15 and 18 months for viral load levels, using a branched DNA technology. Viral load levels were classified as undetectable (< 50 copies/ml); intermediate (50-3 500 cp/ml) or high (> 3 500 cp/ml). RESULTS: Of the 350 women screened for HIV 22 (6.3 %) were positive for HIV-1, but only 18 children were duly tested until 18 months. Viral load levels were undetectable at 6 weeks in 61.1 % of the children; intermediate in 38.9 % and no child had a high VL (> 3 500 cp/ml). At 6 months 5 of 7 children with intermediate levels had dropped to undetectable levels. By 15-18 months, a total of 16 children (88.9 %) had undetectable levels while 2 children (11.1 %) with detectable levels were confirmed to be HIV positive using ELISA test and immunoblot analysis. CONCLUSIONS: We conclude that the rate of HIV-1 MTCT with NVP is about 11 % in CHU Yaounde.


Assuntos
Fármacos Anti-HIV/administração & dosagem , Países em Desenvolvimento , Infecções por HIV/prevenção & controle , HIV-1/efeitos dos fármacos , Transmissão Vertical de Doenças Infecciosas/prevenção & controle , Nevirapina/administração & dosagem , Complicações Infecciosas na Gravidez/tratamento farmacológico , Administração Oral , Fármacos Anti-HIV/efeitos adversos , Camarões , Feminino , Seguimentos , Infecções por HIV/transmissão , Hospitais de Ensino , Humanos , Recém-Nascido , Nevirapina/efeitos adversos , Gravidez , Estudos Prospectivos , Carga Viral
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA